Shinko Asset Management Company’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$216K Sell
2,551
-550
-18% -$46.2K ﹤0.01% 316
2016
Q2
$252K Sell
3,101
-1,400
-31% -$107K ﹤0.01% 309
2016
Q1
$322K Sell
4,501
-1,300
-22% -$87.2K ﹤0.01% 272
2015
Q4
$413K Buy
5,801
+37
+0.6% +$2.49K ﹤0.01% 254
2015
Q3
$354K Sell
5,764
-1,500
-21% -$105K ﹤0.01% 286
2015
Q2
$527K Buy
7,264
+6,500
+851% +$480K 0.01% 155
2015
Q1
$59K Buy
764
+300
+65% +$21.5K ﹤0.01% 393
2014
Q4
$31K Sell
464
-2,880
-86% -$182K ﹤0.01% 607
2014
Q3
$203K Sell
3,344
-1,320
-28% -$81.3K ﹤0.01% 227
2014
Q2
$274K Buy
4,664
+4,000
+602% +$234K ﹤0.01% 198
2014
Q1
$38K Sell
664
-1,940
-75% -$104K ﹤0.01% 571
2013
Q4
$139K Buy
2,604
+1,804
+226% +$107K ﹤0.01% 269
2013
Q3
$49K Hold
800
﹤0.01% 481
2013
Q2
$49K Buy
+800
New +$47.7K ﹤0.01% 475

Other funds holding DGX

Shinko Asset Management Company's DGX Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Quest Diagnostics (DGX) stake by 18% in Q3 2016, selling an estimated $46.2K and leaving 2,551 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Shinko Asset Management Company first reported a position in DGX in Q2 2013 and has held it in 14 quarters since. The position peaked at $527K in Q2 2015. 559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

  • Shinko Asset Management Company held 2,551 shares of Quest Diagnostics worth $216K as of Q3 2016.
  • Shinko Asset Management Company sold 550 Quest Diagnostics shares in Q3 2016, an estimated $46.2K.
  • Quest Diagnostics made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #316 holding.
  • Shinko Asset Management Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 14 quarters since.
  • Shinko Asset Management Company's Quest Diagnostics position peaked at $527K in Q2 2015.
  • 559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.